LONDON, June 4 (Xinhua) -- Investigation into the incident of bacteria infection, which killed one baby and affected 14 others, has been launched, local authorities announced on Wednesday.
The Public Health England (PHE) and the Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that they are investigating 15 cases of blood poisoning caused by a bacteria known as Bacillus cereus.
Those affected babies were scattered at about six hospitals across England, receiving neonatal intensive cares as many of which were premature and very vulnerable.
MHRA said "one baby has sadly died but the others are responding to antibiotic treatment."
"The cases have been strongly linked with a number of batches of a particular form of intravenous liquid called parenteral nutrition which was given to the babies. This contains a variety of nutrients that are delivered directly into the babies' bloodstream when they have problems ingesting food via their mouth," MHRA said, adding that this batch of product is produced by ITH Pharma Limited.
The company has no formal responding for the incident, but recalled the product Wednesday afternoon.
London based Guy's and St Thomas's Hospital, where the one infected baby died, made a statement Wednesday saying that the bacterial infection in the neonatal intensive care unit at the hospital has been identified on Saturday.
The hospital said three babies there have been affected, but one of those died on June 1, and the other two are responding well to antibiotics.
MHRA has issued a Class 1 drug alert, and all neonatology units across the country have been informed being aware of the incident, although the product was only issued to a limited number of neonatal units.
"This is a very unfortunate incident and PHE have been working closely with MHRA to investigate how these babies could have become infected," said Mike Catchpole, PHE incident director.
"We have acted quickly to investigate this issue alongside MHRA and we have taken action to ensure that the affected batches and any remaining stock of this medicine is not being used in hospitals," said Catchpole.